The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome

Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion

(2013) Maolan Li et al.   MEDICAL ONCOLOGY

MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma

(2012) Tsung-Chieh Shih et al.   JOURNAL OF HEPATOLOGY

Differential Proteomic Analysis of Human Glioblastoma and Neural Stem Cells Reveals HDGF as a Novel Angiogenic Secreted Factor

(2012) Cécile Thirant et al.   STEM CELLS

Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma

(2011) Shuang Wang et al.   HISTOPATHOLOGY

Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas

(2011) Shu-Shong Hsu et al.   JOURNAL OF NEURO-ONCOLOGY

Expression and Clinical Significance of Hepatoma-Derived Growth Factor as a Prognostic Factor in Human Hilar Cholangiocarcinoma

(2010) Yan-feng Liu et al.   ANNALS OF SURGICAL ONCOLOGY

Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma

(2009) Annika Juergens et al.   ANNALS OF NEUROLOGY

Primary central nervous system lymphoma: The role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy

(2008) Meltem Ekenel et al.   CANCER

Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)

(2008) D. de Jong et al.   JOURNAL OF CLINICAL PATHOLOGY

Long-term survival in primary CNS lymphoma treated by high-dose methotrexate monochemotherapy: role of STAT6 activation as prognostic determinant

(2008) Seung-Ho Yang et al.   JOURNAL OF NEURO-ONCOLOGY